Evidence map›Paper›PMID 29190303›Full record

ReviewPLoS neglected tropical diseases2017

Scabies in the age of increasing drug resistance.

Samar Khalil, Ossama Abbas, Abdul Ghani Kibbi, Mazen Kurban

Registry-linked trialAbstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06396507 (Comparing Sulfur to Different Regimes of Permethrin for the Treatment of Scabies), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06396507 phase3completednot on this mapstarted 2022, after this paper: background citation

Comparing Sulfur to Different Regimes of Permethrin for the Treatment of Scabies

TypeinterventionalSponsorDamascus UniversityRan2022 to 2022Enrolled250ConditionsScabiesArmsPermethrin Solution, Sulfur
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Comparison of in vitro Killing Effect ofClinical, cosmetic and investigational dermatology · 2022
    Article
  12. Bullous Scabies in an Immunocompromised Host.Case reports in infectious diseases · 2022
    Article
  13. Article
  14. [Parasitoses in childhood].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  15. Article
  16. [Scabies-Renaissance of an ectoparasite infection : Diagnosis and therapy-How to proceed in practice].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Control Strategies for Scabies.Tropical medicine and infectious disease · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samar KhalilDepartment of Dermatology, American University of Beirut, Beirut, Lebanon.
Ossama AbbasDepartment of Dermatology, American University of Beirut, Beirut, Lebanon.
Abdul Ghani KibbiDepartment of Dermatology, American University of Beirut, Beirut, Lebanon.
Mazen KurbanDepartment of Dermatology, American University of Beirut, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scabies is an infestation of the skin by the mite Sarcoptes scabiei. It manifests with pruritic erythematous papules and excoriations, in addition to the pathognomonic burrows. Multiple drugs can be used for treatment, but resistance to conventional therapy is increasing throughout the years. This paper will review the mechanisms of resistance proposed in the literature and some of the potential solutions to this problem.

Indexed as

Insecticide ResistanceAnimalsATP-Binding Cassette TransportersHumansInsecticidesSarcoptes scabieiScabiesSkinSodium ChannelsATP-Binding Cassette TransportersInsecticidesSodium Channels

Identifiers

PMID29190303
PMCPMC5708620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.